Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Double-Blind, Placebo-Controlled Phase 3 AIPAC-003 Trial - Testing Eftilagimod Alpha in Pts With HER2-/Low mBC Receiving Paclitaxel, Following an Open-Label Dose Optimization"

By Insights from 2023 ASCO® Annual Meeting FEATURING Nuhad Ibrahim

60 views

June 15, 2023

Comments 0

ASCO® 2023 Insights: "Practical Implications of SONIA Trial Results …

Insights from 2023 ASCO® Annual Meeting

N. El Saghir

533 views

ASCO® 2023 Insights: "Randomised Open-Label Phase II FAIM Study - In…

Insights from 2023 ASCO® Annual Meeting

I. Browne

87 views

ASCO® 2023 Insights: "Real-World Patient Characteristics & Treatment…

Insights from 2023 ASCO® Annual Meeting

J. Meisel

285 views

ASCO® 2023 Insights: "Breast Cancer Surgery - Too Much, Too Little, …

Insights from 2023 ASCO® Annual Meeting

S. Khan

136 views

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribo…

Insights from 2023 ASCO® Annual Meeting

N. McAndrew

307 views

ASCO® 2023 Insights: "BRCA Alterations - Beyond Breast and Ovarian C…

Insights from 2023 ASCO® Annual Meeting

T. Yap

141 views

ASCO® 2023 Insights: "evERA Breast Cancer Phase III Study - Giredest…

Insights from 2023 ASCO® Annual Meeting

E. Mayer

273 views

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO Stud…

Insights from 2023 ASCO® Annual Meeting

A. Van Ommen - Nijhof

117 views

ASCO® 2023 Insights: "Primary Outcome Analysis of the Phase 3 SONIA …

Insights from 2023 ASCO® Annual Meeting

N. Wortelboer

66 views

ASCO® 2023 Insights: "Effects of Ovarian Ablation or Suppression on …

Insights from 2023 ASCO® Annual Meeting

R. Gray

333 views

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capeci…

Insights from 2023 ASCO® Annual Meeting

C. Bohnenkamp

362 views

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Are and…

Insights from 2023 ASCO® Annual Meeting

E. Stringer-Reasor

378 views

ASCO® 2023 Insights: "Double-Blind, Placebo-Controlled Phase 3 AIPAC…

Insights from 2023 ASCO® Annual Meeting

N. Ibrahim

60 views

ASCO® 2023 Insights: "Prognostic Impact of Adjuvant Endocrine Therap…

Insights from 2023 ASCO® Annual Meeting

Y. Takahashi

104 views

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Rand…

Insights from 2023 ASCO® Annual Meeting

P. Conte

760 views

ASCO® 2023 Insights: Role of Endocrine Therapy Timing Intake in Pts …

Insights from 2023 ASCO® Annual Meeting

S. Giacchetti

644 views

ASCO® 2023 Insights: "Primary Results of NCCH1607/PATHWAY, an Asian …

Insights from 2023 ASCO® Annual Meeting

T. Kogawa

111 views

ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing Primar…

Insights from 2023 ASCO® Annual Meeting

T. Shien

355 views

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Arms in…

Insights from 2023 ASCO® Annual Meeting

D. Wolf

104 views

ASCO® 2023 Insights: "lidERA Breast Cancer Phase III Adjuvant Study …

Insights from 2023 ASCO® Annual Meeting

C. Geyer

345 views

ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarker for…

Insights from 2023 ASCO® Annual Meeting

W. Audeh

239 views

ASCO® 2023 Insights: "Late Recurrences in ER+ Breast Cancer - What E…

Insights from 2023 ASCO® Annual Meeting

M. Gnant

643 views

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, TROPI…

Insights from 2023 ASCO® Annual Meeting

P. Tarantino

8.2K views

ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial - Phar…

Insights from 2023 ASCO® Annual Meeting

C. Becherini, L. Livi

207 views

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials Inclu…

Insights from 2023 ASCO® Annual Meeting

H. Rugo, K. Jhaveri

1.9K views

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials Inclu…

Insights from 2023 ASCO® Annual Meeting

H. Rugo, K. Jhaveri

4.8K views

ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Trial - …

Insights from 2023 ASCO® Annual Meeting

N. El Saghir

263 views

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

830 views

ASCO® 2023 Insights: "Comparative OS of Pts in Trials of CKD4/6i in …

Insights from 2023 ASCO® Annual Meeting

C. Kappel

325 views

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuv…

Insights from 2023 ASCO® Annual Meeting

M. Ignatiadis

217 views

ASCO® 2023 Insights: "Are We Splitting HERs? The Highs and Lows"

Insights from 2023 ASCO® Annual Meeting

D. Rimm

231 views

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNBC"

Insights from 2023 ASCO® Annual Meeting

H. Han

854 views

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abemacicli…

Insights from 2023 ASCO® Annual Meeting

R. Patel

817 views

ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Risk' Diseas…

Insights from 2023 ASCO® Annual Meeting

J. Plichta

292 views

ASCO® 2023 Insights: "Oral Elacestrant vs. Standard-of-Care in ER+/H…

Insights from 2023 ASCO® Annual Meeting

V. Kaklamani

113 views

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - S…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

704 views

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant Sacit…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

2.3K views

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes …

Insights from 2023 ASCO® Annual Meeting

M. Tesch

119 views

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With HER2+ …

Insights from 2023 ASCO® Annual Meeting

Y. Yamamoto

381 views

Login

Login

Join VuMedi